Voyager Therapeutics Inc.
VYGR | NASDAQ
$3.10
+$0.02 (+0.65%)
Sep 22, 2026, 11:11 AM ET · Market open
Market Data
Market Cap $186.1M
Enterprise Value $102.33M
Beta 1.32
Average Volume 580.91K
Shares Outstanding (Diluted) 60.55M
Shares Change YoY 3.21%
Institutional Ownership 56.34%
Exchange NASDAQ
ISIN US92915B1061
Price Performance
Price Change 1M -9.4%
Price Change 3M -16.8%
Price Change 6M -23.6%
Price Change YTD -23.6%
Price Change 1Y -27.0%
Price Change 3Y -59.5%
Price Change 5Y 4.8%
1M CAGR (ann.) -5.8%
1Y CAGR (ann.) -31.4%
5Y CAGR (ann.) -1.3%
All-Time CAGR -14.9%
Valuation
PE Ratio -1.70
Forward PE N/A
PEG Ratio 0.96
Forward PEG 0.07
PS Ratio 5.40
Forward PS 4.00
PB Ratio 1.21
P/FCF Ratio -1.20
P/Adj. FCF Ratio -1.10
P/OCF Ratio -1.55
EV/Sales 2.97
EV/EBIT -0.95
EV/EBITDA -0.99
EV/FCF -0.66
Earnings Yield -58.8%
FCF Yield -83.2%
Adj. FCF Yield -90.9%
Financial Health
Net Cash $83.77M
Total Debt $32.57M
Cash & Short-Term Investments $116.34M
Total Assets $197.75M
Current Ratio 7.51
Quick Ratio 7.51
Debt / Equity Ratio 0.21
Debt / EBITDA -0.32
Debt / FCF -0.21
OCF / Debt -4.73
Interest Coverage 0.00
Altman Z-Score -1.92
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin -104.2%
Operating Profit Margin -340.1%
EBITDA Margin -298.5%
Net Profit Margin -312.6%
FCF Margin -449.4%
Adj. FCF Margin -491.1%
SBC / Revenue 34.5%
SBC Impact (per share) -9.3%
Returns
Return on Assets -54.5%
Return on Equity -57.9%
Return on Invested Capital -62.4%
Return on Capital Employed -64.7%
Return on Tangible Assets -54.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -43.9%
Revenue CAGR 5Y -23.6%
Revenue CAGR 10Y 6.5%
EPS CAGR 3Y -92.8%
EPS CAGR 5Y -85.8%
EPS CAGR 10Y 17.4%
FCF CAGR 3Y -67.9%
FCF CAGR 5Y -133.0%
FCF CAGR 10Y -17.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 21
EPS Growth Next 3Y 19.5%
Revenue Growth Next 3Y 47.3%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.41
EPS Growth Est (next Q) -12.8%
Revenue Est (next Q) $6.35M
Revenue Growth Est (next Q) -52.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $14.40
Price Target Upside 367.5%
Cash Flow
Operating Cash Flow $-153.99M
Free Cash Flow $-154.85M
Adj. Free Cash Flow $-169.24M
FCF Per Share -$2.01
OCF Per Share -$1.99
OCF/S Ratio -349.9%
Income Statement
Revenue $34.46M
Gross Profit $-35.89M
Operating Income $-117.19M
EBITDA $-102.85M
Net Income $-107.73M
EPS (Diluted) -$1.81
Revenue / Employee $244.39K
Profit / Employee $-764.03K
Employees 141
Add to Watchlist
Select watchlists to add or remove VYGR